Jeffrey Pollak, MD

Dr. Pollak went to medical school at the Columbia University College of Physicians & Surgeons and subsequently did his Diagnostic Radiology residency at the Columbia-Presbyterian Medical Center. His fellowship in Vascular & Interventional Radiology was at the Hospital of the University of Pennsylvania. He then joined the Yale University School of Medicine Department of Radiology and Biomedical Imaging in the section of V&IR and served as the section chief and director of the fellowship program in this sub-specialty for over two decades. While active in all aspects of vascular & interventional radiology, his current major interests are embolotherapy (embolization), including for acquired and congenital vascular abnormalities and malformations (other than in the brain), fibroids, and malignancies, as well as other minimally invasive treatments for tumors, including local ablation. In addition, he is an expert in vascular procedures in the liver, such as intrahepatic portosystemic shunts and venous procedures, such as inferior vena cava filters.

Dr. Pollak is the current director of the multidisciplinary Yale Hereditary Hemorrhagic Telangiectasia Program, which was started as the first of its kind in the world in the early 1990s. As such, he has extensive experience in the evaluation and management of patients with this genetic disorder, with particular expertise in embolization of pulmonary arteriovenous malformations, which frequently occur in this population. Dr. Pollak is also the co-director of the Yale Pulmonary Embolism Response Team, a multidisciplinary group of physicians interested in the advancement of the management of patients with this condition, especially those with more severe manifestations.